首页> 外文期刊>Nature reviews Cancer >Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
【24h】

Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

机译:反思卵巢癌II:降低高级浆液性卵巢癌的死亡率

获取原文
获取原文并翻译 | 示例
           

摘要

High-grade serous ovarian cancer (HGSOC) accounts for 70-80% of ovarian cancer deaths, and overall survival has not changed significantly for several decades. In this Opinion article, we outline a set of research priorities that we believe will reduce incidence and improve outcomes for women with this disease. This 'roadmap' for HGSOC was determined after extensive discussions at an Ovarian Cancer Action meeting in January 2015.
机译:高度浆液性卵巢癌(HGSOC)占卵巢癌死亡人数的70-80%,几十年来总体生存率并未发生显着变化。在这篇观点文章中,我们概述了一系列研究重点,我们认为这将减少患有这种疾病的女性的发病率并改善其结局。 HGSOC的“路线图”是在2015年1月的卵巢癌行动会议上进行广泛讨论后确定的。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号